Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress
Condition(s):Postpartum HemorrhageLast Updated:September 24, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Postpartum HemorrhageLast Updated:September 24, 2020Completed
Condition(s):Blood Loss, SurgicalLast Updated:June 1, 2007Completed
Condition(s):Postpartum HemorrhageLast Updated:February 20, 2014Completed
Condition(s):Postpartum HemorrhageLast Updated:September 21, 2012Completed
Condition(s):Postpartum HemorrhageLast Updated:March 9, 2020Unknown status
Condition(s):Vasospastic AnginaLast Updated:July 22, 2020Unknown status
Condition(s):SpasmLast Updated:August 4, 2020Unknown status
Condition(s):Variant AnginaLast Updated:February 9, 2018Unknown status
Condition(s):Angina Pectoris, VariantLast Updated:April 6, 2009Unknown status
Condition(s):Angina Pectoris, VariantLast Updated:January 2, 2024Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.